JENNIFER JONES: Open Payments
NPI 1104345024 · LEBANON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,123 in 47 payments from 10 companies in 2025. Trend: 2023 $681 · 2024 $152 · 2025 $1,123
Food & beverage: $1,011Education: $111
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 14 | $355 |
| Neurocrine BioSciences, Inc. | 7 | $166 |
| Teva Pharmaceuticals USA, Inc. | 4 | $159 |
| Janssen Pharmaceuticals, Inc | 5 | $123 |
| Otsuka America Pharmaceutical, Inc. | 6 | $105 |
| ABBVIE INC. | 5 | $98 |
| Lundbeck LLC | 2 | $45 |
| Vanda Pharmaceuticals Inc. | 2 | $36 |
| LNHC, Inc | 1 | $21 |
| Luye Pharma (USA) Ltd. | 1 | $15 |
Products named: COBENFY, INGREZZA, INVEGA SUSTENNA, VRAYLAR, REXULTI, ABILIFY ASIMTUFII, FANAPT, AUSTEDO XR.
Industry payments across OH — which companies pay providers there.
